Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D006801:Humans; D007109:Immunity; D007153:Immunologic Deficiency Syndromes / Q000209:etiology*; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental; D013256:Steroids / Q000097:blood; D013601:T-Lymphocytes / Q000276:immunology
D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D013256:Steroids